Supernus Pharmaceuticals
SUPN
#4182
Rank
โ‚ฌ2.24 B
Marketcap
39,23ย โ‚ฌ
Share price
1.29%
Change (1 day)
11.52%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ1.21 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ1.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.31 B13.75%
2023-12-31โ‚ฌ1.15 B-27.18%
2022-12-31โ‚ฌ1.58 B6.41%
2021-12-31โ‚ฌ1.49 B21.97%
2020-12-31โ‚ฌ1.22 B18.06%
2019-12-31โ‚ฌ1.03 B21.18%
2018-12-31โ‚ฌ0.85 B141.61%
2017-12-31โ‚ฌ0.35 B20.2%
2016-12-31โ‚ฌ0.29 B70.6%
2015-12-31โ‚ฌ0.17 B53.39%
2014-12-31โ‚ฌ0.11 B39.93%
2013-12-31โ‚ฌ80.37 M13.11%
2012-12-31โ‚ฌ71.05 M71.74%
2011-12-31โ‚ฌ41.37 M17.07%
2010-12-31โ‚ฌ35.34 M-36.63%
2009-12-31โ‚ฌ55.76 M1.08%
2008-12-31โ‚ฌ55.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ6.31 B 417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ98.71 B 7,995.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ83.21 B 6,724.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ72.30 B 5,829.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 13,480.98%๐Ÿ‡บ๐Ÿ‡ธ USA